Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Using big data from real-world Australian rheumatology encounters to enhance clinical care and research.

Littlejohn GO, Tymms KE, Smith T, Griffiths HT, Griffiths HT.

Clin Exp Rheumatol. 2019 Nov 16. [Epub ahead of print]

PMID:
31820719
2.

The Relation of Physical Comorbidity and Multimorbidity to Fibromyalgia, Widespread Pain, and Fibromyalgia-related Variables.

Wolfe F, Ablin J, Guymer EK, Littlejohn GO, Rasker JJ.

J Rheumatol. 2019 Aug 1. pii: jrheum.190149. doi: 10.3899/jrheum.190149. [Epub ahead of print]

PMID:
31371651
3.

Chronic pain syndromes: overlapping phenotypes with common mechanisms.

Littlejohn GO, Guymer E.

F1000Res. 2019 Mar 5;8. pii: F1000 Faculty Rev-255. doi: 10.12688/f1000research.16814.1. eCollection 2019. Review.

4.

Fibromyalgia has a high prevalence and impact in cardiac failure patients.

Gist AC, Guymer EK, Ajani AE, Littlejohn GO.

Eur J Rheumatol. 2017 Dec;4(4):245-249. doi: 10.5152/eurjrheum.2017.17026. Epub 2017 Nov 2.

5.

Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia.

Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO.

Int J Rheum Dis. 2018 Mar;21(3):639-646. doi: 10.1111/1756-185X.13055. Epub 2017 Mar 13.

PMID:
28296177
6.

Rumination modulates stress and other psychological processes in fibromyalgia.

Malin K, Littlejohn GO.

Eur J Rheumatol. 2015 Dec;2(4):143-148. Epub 2015 Aug 21.

7.

Is there a role for opioids in the treatment of fibromyalgia?

Littlejohn GO, Guymer EK, Ngian GS.

Pain Manag. 2016 May;6(4):347-55. doi: 10.2217/pmt-2016-0012. Epub 2016 Jun 14.

PMID:
27296831
8.

Psychological factors mediate key symptoms of fibromyalgia through their influence on stress.

Malin K, Littlejohn GO.

Clin Rheumatol. 2016 Sep;35(9):2353-7. doi: 10.1007/s10067-016-3315-9. Epub 2016 May 31.

PMID:
27245234
9.

Fibromyalgia onset has a high impact on work ability in Australians.

Guymer EK, Littlejohn GO, Brand CK, Kwiatek RA.

Intern Med J. 2016 Sep;46(9):1069-74. doi: 10.1111/imj.13135.

PMID:
27242134
10.

PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis.

Lester S, Hewitt AW, Ruediger CD, Bradbury L, De Smit E, Wiese MD, Black R, Harrison A, Jones G, Littlejohn GO, Merriman TR, Shenstone B, Smith MD, Rischmueller M, Brown MA, Hill CL.

RMD Open. 2016 Apr 7;2(1):e000246. doi: 10.1136/rmdopen-2016-000246. eCollection 2016.

11.

Repetitive transcranial magnetic stimulation for pain: is it too early to standardise repetitive transcranial magnetic stimulation protocols?

Fitzgibbon BM, Hoy KE, Guymer EK, Littlejohn GO, Fitzgerald PB.

Pain. 2016 May;157(5):1174-5. doi: 10.1097/j.pain.0000000000000503. No abstract available.

PMID:
27081840
12.

In Clinical Practice, the Term "Central Sensitivity Score" Is More Useful Than the Term "Polysymptomatic Distress Scale": Comment on the Editorial by Wolfe.

Littlejohn GO, Guymer EK.

Arthritis Rheumatol. 2015 Sep;67(9):2553. doi: 10.1002/art.39213. No abstract available.

13.

Drs. Littlejohn and Guymer reply.

Littlejohn GO, Guymer EK.

J Rheumatol. 2014 Nov;41(11):2324. doi: 10.3899/jrheum.140753. No abstract available.

PMID:
25362719
14.

Whiplash: same elephant, different room.

Littlejohn GO, Guymer EK.

J Rheumatol. 2014 Mar;41(3):411-3. doi: 10.3899/jrheum.131541. No abstract available.

PMID:
24585522
15.

Stress modulates key psychological processes and characteristic symptoms in females with fibromyalgia.

Malin K, Littlejohn GO.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6 Suppl 79):S64-71. Epub 2013 Oct 21.

PMID:
24143887
16.

Psychological control is a key modulator of fibromyalgia symptoms and comorbidities.

Malin K, Littlejohn GO.

J Pain Res. 2012;5:463-71. doi: 10.2147/JPR.S37056. Epub 2012 Nov 2.

17.

Personality and fibromyalgia syndrome.

Malin K, Littlejohn GO.

Open Rheumatol J. 2012;6:273-85. Epub 2012 Sep 7.

18.

Clinical characteristics of 150 consecutive fibromyalgia patients attending an Australian public hospital clinic.

Guymer EK, Maruff P, Littlejohn GO.

Int J Rheum Dis. 2012 Aug;15(4):348-57. doi: 10.1111/j.1756-185X.2012.01767.x. Epub 2012 Jul 9.

PMID:
22898214
19.

Abatacept in the treatment of lupus.

Hoi AY, Littlejohn GO.

Expert Opin Biol Ther. 2012 Oct;12(10):1399-406. doi: 10.1517/14712598.2012.713934. Epub 2012 Aug 7.

PMID:
22870890
20.

Neuroticism in young women with fibromyalgia links to key clinical features.

Malin K, Littlejohn GO.

Pain Res Treat. 2012;2012:730741. doi: 10.1155/2012/730741. Epub 2012 Feb 19.

21.

Management strategies for fibromyalgia.

Le Marshall KF, Littlejohn GO.

Open Access Rheumatol. 2011 Jul 12;3:47-51. eCollection 2011.

22.

The use of opioids in fibromyalgia.

Ngian GS, Guymer EK, Littlejohn GO.

Int J Rheum Dis. 2011 Feb;14(1):6-11. doi: 10.1111/j.1756-185X.2010.01567.x. Epub 2010 Aug 23. Review.

PMID:
21303476
23.

Is DISH painful?

Ngian GS, Littlejohn GO.

J Rheumatol. 2010 Sep;37(9):1797-9. doi: 10.3899/jrheum.100519. No abstract available.

PMID:
20810521
24.

Fibromyalgia. Diagnosis and management.

Guymer EK, Littlejohn GO.

Australas Chiropr Osteopathy. 2002 Nov;10(2):81-4.

25.

Measuring quality of life in rheumatic conditions.

Walker JG, Littlejohn GO.

Clin Rheumatol. 2007 May;26(5):671-3. Epub 2006 Nov 24. Review.

26.

Fibromyalgia syndrome: which antidepressant drug should we choose.

Littlejohn GO, Guymer EK.

Curr Pharm Des. 2006;12(1):3-9. Review.

PMID:
16454718
27.

Balanced treatments for fibromyalgia.

Littlejohn GO.

Arthritis Rheum. 2004 Sep;50(9):2725-9. Review. No abstract available.

28.

Models of adjustment to chronic illness: using the example of rheumatoid arthritis.

Walker JG, Jackson HJ, Littlejohn GO.

Clin Psychol Rev. 2004 Aug;24(4):461-88. Review.

PMID:
15245831
29.

Reflex sympathetic dystrophy in adolescents: lessons for adults.

Littlejohn GO.

Arthritis Rheum. 2004 Apr 15;51(2):151-3. Review. No abstract available.

30.

Aminotransferase levels during treatment of rheumatoid arthritis with leflunomide in clinical practice.

Hoi A, Littlejohn GO.

Ann Rheum Dis. 2003 Apr;62(4):379. No abstract available.

31.

A realistic approach to managing patients with fibromyalgia.

Littlejohn GO, Walker J.

Curr Rheumatol Rep. 2002 Aug;4(4):286-92. Review.

PMID:
12126575
32.

Rheumatology.

Littlejohn GO, Morand EF.

Med J Aust. 2002 Jan 7;176(1):41. No abstract available.

PMID:
11840944
33.

Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.

Wluka A, Buchbinder R, Mylvaganam A, Hall S, Harkness A, Lewis D, Littlejohn GO, Miller MH, Ryan PF.

J Rheumatol. 2000 Aug;27(8):1864-71.

PMID:
10955325
34.

The role of sex hormones in pain response.

Johns KR, Littlejohn GO.

Pain. 1999 Oct;83(1):112-4. No abstract available.

PMID:
10577144
35.

Stress system response and rheumatoid arthritis: a multilevel approach.

Walker JG, Littlejohn GO, McMurray NE, Cutolo M.

Rheumatology (Oxford). 1999 Nov;38(11):1050-7. Review.

PMID:
10556255
36.

The safety and efficacy of cyclosporine (Neoral) in rheumatoid arthritis.

Johns KR, Littlejohn GO.

J Rheumatol. 1999 Oct;26(10):2110-3.

PMID:
10529125
37.

Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus.

Kipen Y, Briganti EM, Strauss BJ, Littlejohn GO, Morand EF.

Rheumatology (Oxford). 1999 Jan;38(1):59-65.

PMID:
10334684
38.

Adult-onset Still's disease: a concise review of clues to an important rare syndrome.

Schachna L, Littlejohn GO.

Aust N Z J Med. 1999 Feb;29(1):98-9. No abstract available.

PMID:
10200827
39.

The antiphospholipid antibody syndrome.

Johns KR, Littlejohn GO.

Aust Fam Physician. 1998 Aug;27(8):709-13. Review.

PMID:
9735489
40.

Fibromyalgia syndrome and disability: the neurogenic model.

Littlejohn GO.

Med J Aust. 1998 Apr 20;168(8):398-401. No abstract available.

PMID:
9594951
41.

Pregnancy outcome in systemic lupus erythematosus (SLE): a review of 54 cases.

Johns KR, Morand EF, Littlejohn GO.

Aust N Z J Med. 1998 Feb;28(1):18-22.

PMID:
9544381
42.

Methotrexate use in systemic lupus erythematosus.

Kipen Y, Littlejohn GO, Morand EF.

Lupus. 1997;6(4):385-9.

PMID:
9175024
43.

Rheumatology. 2. Fibromyalgia syndrome.

Littlejohn GO.

Med J Aust. 1996 Oct 7;165(7):387-91. No abstract available.

PMID:
8890848
44.

Advances in the understanding of neuroendocrine function in rheumatic disease.

Morand EF, Cooley H, Leech M, Littlejohn GO.

Aust N Z J Med. 1996 Aug;26(4):543-51. Review. No abstract available.

PMID:
8873939
45.

A database for fibromyalgia.

Littlejohn GO.

Rheum Dis Clin North Am. 1995 May;21(2):527-57. Review.

PMID:
7631042
46.

Combination therapy with methotrexate and sulphasalazine in rheumatoid arthritis--tolerance of therapy.

Axtens RS, Morand EF, Littlejohn GO.

Ann Rheum Dis. 1994 Oct;53(10):703. No abstract available.

47.
48.

Flow cytometric detection of anti-neutrophil cytoplasmic autoantibodies.

Yang YH, Hutchinson P, Littlejohn GO, Boyce N.

J Immunol Methods. 1994 Jun 3;172(1):77-84.

PMID:
8207268
49.

Fibromyalgia syndrome and disease activity in systemic lupus erythematosus.

Morand EF, Miller MH, Whittingham S, Littlejohn GO.

Lupus. 1994 Jun;3(3):187-91.

PMID:
7951304
50.

Fibromyalgia syndrome: assessment of the severity of the condition 2 years after diagnosis.

Granges G, Zilko P, Littlejohn GO.

J Rheumatol. 1994 Mar;21(3):523-9.

PMID:
8006897

Supplemental Content

Loading ...
Support Center